Novo Nordisk open to direct New York listing, CEO Doustdar tells FT

2

Sept 23 (Reuters) – Novo Nordisk is open to considering a direct New York Stock Exchange listing, replacing the American depositary receipts through which US investors currently trade its shares, CEO

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)